Form 8-K - Current report:
SEC Accession No. 0001193125-23-159833
Filing Date
2023-06-02
Accepted
2023-06-02 16:10:03
Documents
12
Period of Report
2023-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d474410d8k.htm   iXBRL 8-K 38415
  Complete submission text file 0001193125-23-159833.txt   160859

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20230601.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20230601_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20230601_pre.xml EX-101.PRE 11271
6 EXTRACTED XBRL INSTANCE DOCUMENT d474410d8k_htm.xml XML 3407
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 23988765
SIC: 2834 Pharmaceutical Preparations